CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

BUENOS AIRES - Argentina's award-winning mare Polo Pureza will have her genes, or at least most of them, live on in five ...

Scientists at Argentine biotech firm Kheiron have produced the world's first genetically edited horses using a technique called CRISPR-Cas9 ... which is what nature does, but we do it faster ...

The slow ramp-up may also give competitors more time to advance their own gene therapies, potentially eroding CRISPR's first-mover advantage in the market. What challenges does CRISPR face in the ...

Still, even if this does prove successful, that doesn’t mean that the pipeline will be. But it’s a huge factor in showing that, not only will the FDA approve a CRISPR/CAS9 treatment ...

President Donald Trump is taking significant steps to eliminate DEI programs at the federal level. A memo from the U.S. Office of Personnel Management, issued Tuesday evening, instructed that all ...

For many years, cloned ponies have excelled in the prestigious equestrian sport of polo, and the sport has now taken a ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

While Morocco has yet to embrace genome editing, specifically CRISPR, early research is underway ... This means that the final product does not contain any foreign genes, which makes it more ...